These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 17239261)

  • 41. A critique on contemporary reporting of likelihood ratios in test power analysis.
    Weissler AM; Bailey KR
    Mayo Clin Proc; 2004 Oct; 79(10):1317-8. PubMed ID: 15473417
    [No Abstract]   [Full Text] [Related]  

  • 42. Evaluating Prognostic Markers Using Relative Utility Curves and Test Tradeoffs.
    Baker SG; Kramer BS
    J Clin Oncol; 2015 Aug; 33(23):2578-80. PubMed ID: 26124476
    [No Abstract]   [Full Text] [Related]  

  • 43. Metastatic gene signatures and emerging novel prognostic tests in the management of early stage breast cancer.
    Tordai A; Liedtke C; Pusztai L
    Clin Exp Metastasis; 2009; 26(7):625-32. PubMed ID: 19381845
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A hybrid approach to identify subsequent breast cancer using pathology and automated health information data.
    Haque R; Shi J; Schottinger JE; Ahmed SA; Chung J; Avila C; Lee VS; Cheetham TC; Habel LA; Fletcher SW; Kwan ML
    Med Care; 2015 Apr; 53(4):380-5. PubMed ID: 25769058
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genomic Grade Index: An important tool for assessing breast cancer tumor grade and prognosis.
    Metzger Filho O; Ignatiadis M; Sotiriou C
    Crit Rev Oncol Hematol; 2011 Jan; 77(1):20-9. PubMed ID: 20138540
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hierarchy of gene expression data is predictive of future breast cancer outcome.
    Chen M; Deem MW
    Phys Biol; 2013 Oct; 10(5):056006. PubMed ID: 24091897
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of likelihood ratio computation to standardize the predictive power of noninvasive cardiovascular tests.
    Montori VM; Ebbert JO
    Mayo Clin Proc; 2000 Apr; 75(4):423-4. PubMed ID: 10761502
    [No Abstract]   [Full Text] [Related]  

  • 48. Gene-expression signatures in breast cancer.
    Kunkler IH
    N Engl J Med; 2003 Apr; 348(17):1715-7; author reply 1715-7. PubMed ID: 12712997
    [No Abstract]   [Full Text] [Related]  

  • 49. Interpreting and integrating risk factors for patients with primary breast cancer.
    Clark GM
    J Natl Cancer Inst Monogr; 2001; (30):17-21. PubMed ID: 11773287
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Performance characteristics of the MammaPrint
    Delahaye LJ; Wehkamp D; Floore AN; Bernards R; Van't Veer LJ; Glas AM
    Per Med; 2013 Nov; 10(8):801-811. PubMed ID: 29776281
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparing the performance of gene expression assays in breast cancer.
    Suthers GK
    Int J Cancer; 2019 Aug; 145(4):1162. PubMed ID: 30895596
    [No Abstract]   [Full Text] [Related]  

  • 52. Breast cancer gene collection permits unbiased studies.
    Sage L
    J Proteome Res; 2006 Mar; 5(3):466. PubMed ID: 16541530
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparative study of joint analysis of microarray gene expression data in survival prediction and risk assessment of breast cancer patients.
    Yasrebi H
    Brief Bioinform; 2016 Sep; 17(5):771-85. PubMed ID: 26504096
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluating use characteristics for the oncotype dx 21-gene recurrence score and concordance with chemotherapy use in early-stage breast cancer.
    Chen C; Dhanda R; Tseng WY; Forsyth M; Patt DA
    J Oncol Pract; 2013 Jul; 9(4):182-7. PubMed ID: 23942918
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of new hematopoietic cell subsets with a polyclonal antibody library specific for neglected proteins.
    Moro M; Crosti M; Creo P; Gallina P; Curti S; Sugliano E; Scavelli R; Cattaneo D; Canidio E; Marconi M; Rebulla P; Sarmientos P; Viale G; Pagani M; Abrignani S
    PLoS One; 2012; 7(4):e34395. PubMed ID: 22496798
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Editorial: gene expression profile assays as an aid in treatment decision making in early-stage breast cancer.
    Lyman GH
    J Oncol Pract; 2007 Jul; 3(4):187-8. PubMed ID: 20859408
    [No Abstract]   [Full Text] [Related]  

  • 57. Economics of cancer care.
    Lyman GH
    J Oncol Pract; 2007 May; 3(3):113-4. PubMed ID: 20859394
    [No Abstract]   [Full Text] [Related]  

  • 58. Can survival prediction be improved by merging gene expression data sets?
    Yasrebi H; Sperisen P; Praz V; Bucher P
    PLoS One; 2009 Oct; 4(10):e7431. PubMed ID: 19851466
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic prognostic and predictive markers in colorectal cancer.
    Walther A; Johnstone E; Swanton C; Midgley R; Tomlinson I; Kerr D
    Nat Rev Cancer; 2009 Jul; 9(7):489-99. PubMed ID: 19536109
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Accessing and integrating data and knowledge for biomedical research.
    Burgun A; Bodenreider O
    Yearb Med Inform; 2008; ():91-101. PubMed ID: 18660883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.